Longevity extension in Drosophila through gut-brain communication

Sci Rep. 2018 May 30;8(1):8362. doi: 10.1038/s41598-018-25382-z.


Aging and chronic disease development are multifactorial processes involving the cumulative effects of metabolic distress, inflammation, oxidative stress and mitochondrial dynamics. Recently, variations in the gut microbiota have been associated with age-related phenotypes and probiotics have shown promise in managing chronic disease progression. In this study, novel probiotic and synbiotic formulations are shown to combinatorially extend longevity in male Drosophila melanogaster through mechanisms of gut-brain-axis communication with implications in chronic disease management. Both the probiotic and synbiotic formulations rescued markers of metabolic stress by managing insulin resistance and energy regulatory pathways. Both formulations also ameliorated elevations in inflammation, oxidative stress and the loss of mitochondrial complex integrity. In almost all the measured pathways, the synbiotic formulation has a more robust impact than its individual components insinuating its combinatorial effect. The concomitant action of the gut microbiota on each of the key risk factors of aging and makes it a powerful therapeutic tool against neurodegeneration, diabetes, obesity, cardiovascular disease and other age-related chronic diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects
  • Aging / metabolism
  • Animals
  • Biomarkers / metabolism
  • Brain / drug effects*
  • Brain / physiology*
  • Drosophila melanogaster
  • Drug Compounding
  • Fatty Acids / metabolism
  • Gastrointestinal Tract / drug effects*
  • Gastrointestinal Tract / physiology*
  • Insulin / metabolism
  • Longevity / drug effects*
  • Oxidative Stress / drug effects
  • Prebiotics*
  • Probiotics / pharmacology*
  • Signal Transduction / drug effects


  • Biomarkers
  • Fatty Acids
  • Insulin
  • Prebiotics